1. Wang, Y.; Zhang, S.; Li, H.; Wang, H.; Zhang, T.; Hutchinson M. R.; Yin, H.*; Wang, X.* (2020) Small-molecule modulators of Toll-like receptors. Accounts Chem. Res., 53, 1046-1055.

2. Kornilov, F.D.^#; Shabalkina, A.V.^#; Lin, C.^#; Volynsky, P.E.; Kot, E.F.; Kayushin, A.L.; Lushpa, V.A.; Goncharuk, M.V.; Arseniev, A.S.; Goncharuk, S.A.*; Wang, X.*; Mineev, K.S.* (2023) The architecture of transmembrane and cytoplasmic juxtamembrane of Toll-like receptors. Nat. Commun., 14, 1503.

3. Li, Y.; Wang, Y.; Lu, L.; Shi, J.*; Wang, X.* (2022) Non-small molecule therapeutics for drug addiction: from pharmacokinetics modulating to synthetic biology. Fundam. Res., Doi:10.1016/j.fmre.2022.09.027

4. Li, H.^#; Peng, Y.^#; Lin, C.; Zhang, X.; Zhang, T.; Wang, Y.; Li, Y.; Wu, S.; Wang, H.; Hutchinson M.; Watkins L.; Wang, X.* (2021) Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling. The Innovation, 2, 100111.

5. Peng, Y.^#; Zhang, X.^#; Zhang, T.; Grace, P.; Li, H.; Wang, Y.; Chen, H.; Watkins L. R.; Hutchinson M. R.; Yin H.; Wang, X.* (2019) Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain. Brain Behav. Immun., 82, 432-444.

6. Wang, Y.^#; Peng, Y.^#; Zhang, B.; Zhang, X.; Li, H.; Wilson, A. J.; Mineev, K. S.; Wang, X.* (2019) Targeting trimeric transmembrane domain 5 of oncogenic latent membrane protein 1 using a computationally designed peptide. Chem. Sci., 10, 7584-7590.

7. Wang, X.*; Northcutt, A. L.; Cochran, T. A.; Zhang, X.; Fabisiak, T. J.; Haas, M. E.; Amat, J.; Li, H.; Rice, K. C.; Maier, S. F; Bachtell, R. K.; Hutchinson, M. R.; Watkins, L. R. (2019) Methamphetamine activates Toll-like receptor 4 to induce central immune signaling within the ventral tegmental area and contributes to extracellular dopamine increase in the nucleus accumbens shell. ACS Chem. Neurosci., 10, 3622-3634.

8. Wang, F.^#; Jin, T.^#; Li, H.^#; Long, H.; Liu, Y.; Jin, S.; Lu, Y.; Peng, Y.; Liu, C.; Zhao, L.*; Wang, X.* (2023) Cannabidivarin alleviates α-synuclein aggregation via DAF-16 in caenorhabditis elegans. FASEB J., 37, e22735.

9. Zhang, X.^#; Peng, Y.^#; Grace, P. M.; Metcalf, M. D.; Kwilasz, A. J.; Wang, Y.; Zhang, T.; Wu, S.; Selfridge, B. R.; Portoghese, P. S.; Rice, K. C.; Watkins, L. R.; Hutchinson, M. R.; Wang, X.* (2019) Stereochemistry and innate immune recognition: (+)-Norbinaltorphimine enantioselectively targets myeloid differentiation protein 2 and inhibits Toll-like receptor 4 signaling. FASEB J., 33, 9577-9587.

10. Wang, X.; Lin, C.*; Wu, S.; Zhang, T.; Wang, Y.; Jiang, Y.*; Wang, X.* (2022) Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia. Front. Immunol., 13, 929222.